Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses
- PMID:26555301
- DOI: 10.1080/07391102.2015.1117991
Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses
Abstract
Human leukotriene A4 hydrolase/aminopeptidase (LTA4H) is a zinc metalloenzyme with a dual catalytic activity; conversion of LTA4 into LTB4 and degradation of chemotactic tripeptide Pro-Gly-Pro (PGP). Existing inhibitors, such as SC-57461A, block both catalytic activities of the enzyme, leading to drug failures. Recently, a novel compound, ARM1, was reported to selectively inhibit the hydrolase activity of LTA4H while sparing its aminopeptidase activity. However, the molecular understanding of such preferential inhibitory mechanism remains obscure. The discovery of ARM1 prompted us to further explore its binding theme and provide more insight into the structural and dual mechanistic features of LTA4H protein. To accomplish this, we embarked on wide range of computational tools, including comparative molecular dynamics (MDs) simulations and postdynamic analyses for LTA4H and in complex with ARM1, PGP, ARM1-PGP, and SC-57461A. MD analysis reveals that the binding of ARM1 exhibits a more stable active site and overall stable protein conformation when compared to the nonselective inhibitor SC-57461A. In addition, MM/GBSA-binding free energy calculation also reveals that ARM1 exhibit a lower binding affinity, when compared to the nonselective inhibitor SC-57461A - which is in a great agreement with experimental data. Per residue energy decomposition analysis showed that Phe314, Val367, Tyr378, Trp311, Pro382, and Leu369 are key residues critical for the selective inhibition of the epoxide hydrolase activity of LTA4H by ARM1. Findings from this report will not only provide more understanding into the structural, dynamic, and mechanistic features of LTA4H but would also assist toward the rational design of novel and selective hydrolase inhibitors of LTA4H as anti-inflammatory drugs.
Keywords: ARM1; dual LTA4H hydrolase/aminopeptidase; molecular dynamics; selective inhibition.
Similar articles
- Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.Appiah-Kubi P, Soliman M.Appiah-Kubi P, et al.Cell Biochem Biophys. 2017 Mar;75(1):35-48. doi: 10.1007/s12013-016-0772-3. Epub 2016 Dec 2.Cell Biochem Biophys. 2017.PMID:27914004
- Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.Stsiapanava A, Olsson U, Wan M, Kleinschmidt T, Rutishauser D, Zubarev RA, Samuelsson B, Rinaldo-Matthis A, Haeggström JZ.Stsiapanava A, et al.Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4227-32. doi: 10.1073/pnas.1402136111. Epub 2014 Mar 3.Proc Natl Acad Sci U S A. 2014.PMID:24591641Free PMC article.
- Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.Numao S, Hasler F, Laguerre C, Srinivas H, Wack N, Jäger P, Schmid A, Osmont A, Röthlisberger P, Houguenade J, Bergsdorf C, Dawson J, Carte N, Hofmann A, Markert C, Hardaker L, Billich A, Wolf RM, Penno CA, Bollbuck B, Miltz W, Röhn TA.Numao S, et al.Sci Rep. 2017 Oct 19;7(1):13591. doi: 10.1038/s41598-017-13490-1.Sci Rep. 2017.PMID:29051536Free PMC article.
- Leukotriene A4 hydrolase as a target for cancer prevention and therapy.Chen X, Wang S, Wu N, Yang CS.Chen X, et al.Curr Cancer Drug Targets. 2004 May;4(3):267-83. doi: 10.2174/1568009043333041.Curr Cancer Drug Targets. 2004.PMID:15134534Review.
- Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.Penning TD.Penning TD.Curr Pharm Des. 2001 Feb;7(3):163-79. doi: 10.2174/1381612013398248.Curr Pharm Des. 2001.PMID:11311111Review.
Cited by
- Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry.Mathew B, Oh JM, Abdelgawad MA, Khames A, Ghoneim MM, Kumar S, Nath LR, Sudevan ST, Parambi DGT, Agoni C, Soliman MES, Kim H.Mathew B, et al.ACS Omega. 2022 Feb 24;7(9):8184-8197. doi: 10.1021/acsomega.2c00397. eCollection 2022 Mar 8.ACS Omega. 2022.PMID:35284720Free PMC article.
- S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion.Olesch C, Sirait-Fischer E, Berkefeld M, Fink AF, Susen RM, Ritter B, Michels BE, Steinhilber D, Greten FR, Savai R, Takeda K, Brüne B, Weigert A.Olesch C, et al.J Clin Invest. 2020 Oct 1;130(10):5461-5476. doi: 10.1172/JCI136928.J Clin Invest. 2020.PMID:32663191Free PMC article.
- Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition.Shunmugam L, Soliman MES.Shunmugam L, et al.RSC Adv. 2018 Dec 18;8(73):42210-42222. doi: 10.1039/c8ra07346e. eCollection 2018 Dec 12.RSC Adv. 2018.PMID:35558797Free PMC article.
- Molecular Structure-Based Screening of the Constituents ofCalotropis procera Identifies Potential Inhibitors of Diabetes Mellitus Target Alpha Glucosidase.Adinortey CA, Kwarko GB, Koranteng R, Boison D, Obuaba I, Wilson MD, Kwofie SK.Adinortey CA, et al.Curr Issues Mol Biol. 2022 Feb 21;44(2):963-987. doi: 10.3390/cimb44020064.Curr Issues Mol Biol. 2022.PMID:35723349Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous